Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cristina Tanaseanu

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Haematologia|June 1, 2002
The antiphospholipid antibodiesCristina Tanaseanu, Elena Moldoveanu, St Tanaseanu, et al.
European Journal of Internal Medicine|September 29, 2004
The significance of human platelet-activating factor-acetylhydrolase in patients with chronic stable anginaCristina Tanaseanu, Elena Moldoveanu, Tetsuya Kosaka, et al.
European Journal of Internal Medicine|December 28, 2005
Plasma markers of endothelial dysfunction in type 2 diabeticsElena Moldoveanu, Cristina Tanaseanu, Stefanita Tanaseanu, et al.
Journal of Cellular and Molecular Medicine|March 4, 2003
Significance of platelet-activating factor acetylhydrolase in patients with non-insulin-dependent (type 2) diabetes mellitusM Serban, Cristina Tanaseanu, T Kosaka, et al.
Clinical Biochemistry|October 22, 2008
Low basal levels of circulating adiponectin in patients undergoing coronary stenting predict in-stent restenosis, independently of basal levels of inflammatory markers: lipoprotein associated phospholipase A2, and myeloperoxidaseElena Moldoveanu, Bogdan Mut-Vitcu, George R Tanaseanu, et al.
BMC Pulmonary Medicine|September 11, 2009
Efficacy and safety of tigecycline versus levofloxacin for community-acquired pneumoniaCristina Tanaseanu, Slobodan Milutinovic, Petre I Calistru, et al.
Diagnostic Microbiology and Infectious Disease|May 30, 2008
Integrated results of 2 phase 3 studies comparing tigecycline and levofloxacin in community-acquired pneumoniaCristina Tanaseanu, Carlos Bergallo, Osvaldo Teglia, et al.
Autoimmunity|September 19, 2008
Quantification and molecular characterization of regulatory T cells in connective tissue diseasesLeontina Banica, Alina Besliu, Gina Pistol, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Haematologia|June 1, 2002
The antiphospholipid antibodiesCristina Tanaseanu, Elena Moldoveanu, St Tanaseanu, et al.
European Journal of Internal Medicine|September 29, 2004
The significance of human platelet-activating factor-acetylhydrolase in patients with chronic stable anginaCristina Tanaseanu, Elena Moldoveanu, Tetsuya Kosaka, et al.
European Journal of Internal Medicine|December 28, 2005
Plasma markers of endothelial dysfunction in type 2 diabeticsElena Moldoveanu, Cristina Tanaseanu, Stefanita Tanaseanu, et al.
Journal of Cellular and Molecular Medicine|March 4, 2003
Significance of platelet-activating factor acetylhydrolase in patients with non-insulin-dependent (type 2) diabetes mellitusM Serban, Cristina Tanaseanu, T Kosaka, et al.
Clinical Biochemistry|October 22, 2008
Low basal levels of circulating adiponectin in patients undergoing coronary stenting predict in-stent restenosis, independently of basal levels of inflammatory markers: lipoprotein associated phospholipase A2, and myeloperoxidaseElena Moldoveanu, Bogdan Mut-Vitcu, George R Tanaseanu, et al.
BMC Pulmonary Medicine|September 11, 2009
Efficacy and safety of tigecycline versus levofloxacin for community-acquired pneumoniaCristina Tanaseanu, Slobodan Milutinovic, Petre I Calistru, et al.
Diagnostic Microbiology and Infectious Disease|May 30, 2008
Integrated results of 2 phase 3 studies comparing tigecycline and levofloxacin in community-acquired pneumoniaCristina Tanaseanu, Carlos Bergallo, Osvaldo Teglia, et al.
Autoimmunity|September 19, 2008
Quantification and molecular characterization of regulatory T cells in connective tissue diseasesLeontina Banica, Alina Besliu, Gina Pistol, et al.
Pageof 1